Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R A Clift

Showing results (111-120 of 213) with videos related to

Pageof 22
Sort By:
Experimental Hematology|November 1, 1981
Allogeneic bone marrow transplantation for chronic granulocytic leukemiaK C Doney, C D Buckner, E D Thomas, et al.
Annals of the New York Academy of Sciences|January 1, 1976
Marrow transplantation for acute leukemia in manA Fefer, E D Thomas, C D Buckner, et al.
Lancet (London, England)|July 31, 1982
Marrow transplantation for thalassaemiaE D Thomas, C D Buckner, J E Sanders, et al.
Transplantation Proceedings|March 1, 1973
Marrow grafting in identical twins with hematologic malignanciesA Fefer, C D Buckner, R A Clift, et al.
Blood|October 1, 1976
Allogeneic marrow grafting for treatment of aplastic anemia: a follow-up on long-term survivorsR Storb, E D Thomas, C D Buckner, et al.
Haematology and Blood Transfusion|January 1, 1990
Supportive care of the marrow transplant recipient: the Seattle ExperienceK M Sullivan, J Meyers, F B Petersen, et al.
Blood|September 1, 1995
A retrospective analysis of the long-term effect of splenectomy on late infections, graft-versus-host disease, relapse, and survival after allogeneic marrow transplantation for chronic myelogenous leukemiaP Kalhs, I Schwarzinger, G Anderson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1995
High-dose cyclophosphamide, carmustine, and etoposide followed by allogeneic bone marrow transplantation in patients with lymphoid malignancies who had received prior dose-limiting radiation therapyT Demirer, C H Weaver, C D Buckner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1996
Allogeneic marrow transplantation for myelodysplastic syndrome with advanced disease morphology: a phase II study of busulfan, cyclophosphamide, and total-body irradiation and analysis of prognostic factorsJ E Anderson, F R Appelbaum, G Schoch, et al.
Bone Marrow Transplantation|November 1, 1988
Simultaneous infusion of high-dose cytosine arabinoside with cyclophosphamide followed by total body irradiation and marrow infusion for the treatment of patients with advanced hematological malignancyF B Petersen, F R Appelbaum, C D Buckner, et al.
Pageof 22

Showing results (111-120 of 213) with videos related to

Sort By:
Pageof 22
Experimental Hematology|November 1, 1981
Allogeneic bone marrow transplantation for chronic granulocytic leukemiaK C Doney, C D Buckner, E D Thomas, et al.
Annals of the New York Academy of Sciences|January 1, 1976
Marrow transplantation for acute leukemia in manA Fefer, E D Thomas, C D Buckner, et al.
Lancet (London, England)|July 31, 1982
Marrow transplantation for thalassaemiaE D Thomas, C D Buckner, J E Sanders, et al.
Transplantation Proceedings|March 1, 1973
Marrow grafting in identical twins with hematologic malignanciesA Fefer, C D Buckner, R A Clift, et al.
Blood|October 1, 1976
Allogeneic marrow grafting for treatment of aplastic anemia: a follow-up on long-term survivorsR Storb, E D Thomas, C D Buckner, et al.
Haematology and Blood Transfusion|January 1, 1990
Supportive care of the marrow transplant recipient: the Seattle ExperienceK M Sullivan, J Meyers, F B Petersen, et al.
Blood|September 1, 1995
A retrospective analysis of the long-term effect of splenectomy on late infections, graft-versus-host disease, relapse, and survival after allogeneic marrow transplantation for chronic myelogenous leukemiaP Kalhs, I Schwarzinger, G Anderson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1995
High-dose cyclophosphamide, carmustine, and etoposide followed by allogeneic bone marrow transplantation in patients with lymphoid malignancies who had received prior dose-limiting radiation therapyT Demirer, C H Weaver, C D Buckner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1996
Allogeneic marrow transplantation for myelodysplastic syndrome with advanced disease morphology: a phase II study of busulfan, cyclophosphamide, and total-body irradiation and analysis of prognostic factorsJ E Anderson, F R Appelbaum, G Schoch, et al.
Bone Marrow Transplantation|November 1, 1988
Simultaneous infusion of high-dose cytosine arabinoside with cyclophosphamide followed by total body irradiation and marrow infusion for the treatment of patients with advanced hematological malignancyF B Petersen, F R Appelbaum, C D Buckner, et al.
Pageof 22